BIOMERICA, INC. (BMRA) Return on equity 2017–2026
BIOMERICA, INC. (BMRA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-143.5%FY2026 · since FY2017: -20.2% → -143.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -143.5% | -22.4 pp |
| FY2025 | -121.1% | -30.4 pp |
| FY2024 | -90.7% | -29.8 pp |
| FY2023 | -60.9% | -6.5 pp |
| FY2022 | -54.4% | +26.3 pp |
| FY2021 | -80.7% | -61.9 pp |
| FY2020 | -18.8% | +41.3 pp |
| FY2019 | -60.1% | -26.2 pp |
| FY2018 | -33.9% | -13.6 pp |
| FY2017 | -20.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRA financial trends
BMRA RevenueBMRA Net incomeBMRA Net marginBMRA Gross profitBMRA Gross marginBMRA Operating incomeBMRA Operating marginBMRA Operating cash flowBMRA Free cash flowBMRA Capital expendituresBMRA Stock buybacksBMRA Dividends paidBMRA Total assetsBMRA Total liabilitiesBMRA Shareholders’ equityBMRA overview →